(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

KB Home Q2 Earnings Beat Estimates, Simulations Plus and Uber Get Bullish View

June 21st, 2023

KB Home (NYSE: KBH) has released its second-quarter earnings for 2023, exceeding market expectations. The company reported earnings per share (EPS) of $1.94, surpassing the consensus estimate of $1.33 for the period. Looking ahead, KB Home has rev. Read more

Market Buzz: Applied Optoelectronics Surges with SoW Deal for Microsoft

June 21st, 2023

Shares of Applied Optoelectronics, Inc. (Nasdaq: AAOI) surged over 10% in after-hours trading on Wednesday as the company disclosed in a regulatory filing with the SEC that it has entered into a Scope of Work (SoW) agreement with Microsoft Corporatio. Read more

FTC Takes Action Against Amazon for Enrolling Consumers in Amazon Prime Without Consent and Sabotaging Their Attempts to Cancel

June 21st, 2023

Complaint outlines details of company’s knowing failure to address non-consensual subscriptions and cancellation trickery Washington D.C. / CRWE PRESS RELEASE / June 21, 2023 -   The Federal Trade Commission is taking action agains. Read more

Investing in America Tour: Upcoming Biden Administration's Nationwide Roadshow

June 21st, 2023

President Biden is set to lead the Investing in America tour, a three-week nationwide travel blitz highlighting the investments, jobs, and manufacturing boom driven by his economic agenda. The Biden Administration will launch the second installment o. Read more

Buy Ratings for RE, NOTE, NAK, CPRX - Uncovering Growth Prospects

June 21st, 2023

Citigroup initiated coverage on Everest Re Group, Ltd. (NYSE: RE), a global provider of insurance and reinsurance products, with a Buy rating and set a price target of $406. Considering the closing price of $352.74 on Tuesday, the assigned price t. Read more

Analysts Bullish on IREN, SNOW, TDW, SMTC - Unveiling Potential Upsides

June 21st, 2023

HC Wainwright & Co. maintained its Buy rating on Iris Energy Limited (Nasdaq: IREN), an emerging renewable energy company, and raised the price target from $8 to $10.  With $IREN closing at $4.14 on Tuesday, the revised price target indicates. Read more

Patterson Cos' Strong Q4 Earnings and Intel's Strategic Sale Shake the Market

June 21st, 2023

Patterson Companies, Inc. (Nasdaq: PDCO), a leading provider of products and services to the dental, animal health, and rehabilitation markets, announced strong fourth-quarter fiscal 2023 earnings. The company reported earnings per share (EPS) of $0.. Read more

Winnebago: Earnings Beat, Revenues Miss; Chemomab's Liver Fibrosis Trial Data Sparks Surge

June 21st, 2023

Winnebago Industries, Inc. (NYSE: WGO), a well-known manufacturer of recreational vehicles and marine products, reported adjusted earnings per share (EPS) of $2.13 for its its third-quarter fiscal 2023, surpassing the consensus estimate of $1.83. . Read more

Medical Breakthroughs: argenx's VYVGART Hytrulo and Pfizer's TALZENNA Garner FDA Approval

June 21st, 2023

argenx SE (Nasdaq: ARGX) has received approval from the U.S. Food and Drug Administration (FDA) for VYVGART Hytrulo, a subcutaneous injection used to treat generalized myasthenia gravis (gMG) in adult patients who test positive for anti-acetylcholine. Read more

Major Breakthrough: RTX's $1.15B+ Contract, LumiraDx Soars with UK's MHRA Validation

June 20th, 2023

Raytheon Missiles & Defense, a business segment of RTX (NYSE: RTX), has been awarded a significant contract worth $1,151,111,454 for the production of Advanced Medium Range Air-to-Air Missiles (AMRAAM). The contract also includes the provision of AMR. Read more